Pfizer Forks Over $700,000 For Copayment Coupon Claims
Executive Summary
Agreement with New York attorney general resolves allegations Pfizer deceptively advertised that consumers would "pay no more" than $15 or $20 for drugs even though they were often far more expensive.
You may also be interested in...
Abbott's TriCor Off-Label, Kickback Settlement Is Fraction of 2012 Agreement
$25m settlement resolves allegations covering 2006-2008 period; Abbott inked $1.5bn settlement with government six years ago involving Depakote promotion. This is DOJ's fourth pharma deal of the year.
Pfizer Agrees To Oversight Of Charitable Assistance Programs In DOJ Settlement
Second pharma charity kickback settlement in six months resolves claims Pfizer used charity to pay Medicare patient copays for three drugs.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.